From: Adam Bly
To: Jeffrey Epstein <jeevacation@gmail.com>
Subject: Re: Promissory Note
Date: Thu, 29 Nov 2012 00:18:48 +0000
just because we asked.... it would help us with year-end cash planning if you're not amenable, I understand
and I'll ask Vera to just propose a payment schedule for the full amount.
On Nov 28, 2012, at 12:29 PM, Jeffrey Epstein wrote:
why should we discount amount owed?? i don't understand
On Wed, Nov 28, 2012 at 10:48 AM, Adam Bly > wrote:
Begin forwarded message:
From: Vera Savcic <
Date: November 28, 2012 10:42:32 AM EST
To: Adam Bly
Subject: Promissory Note
Revised Payment Proposal
Based on $300k Principal at 24% Default Rate, 365 day basis
Full year interest = $72k with payments to be made as follows:
- Monthly payments of $3k each for 12 months beginning December 2012 = $36k
- Balance of $36k to be paid in 4 installments of $9k each on Aug 31, Sept 30, Oct 31 and Nov 30, 2013 —
or earlier
- 5 business-day cure period applies
We also propose settling the interest payment due for September October and November 2012 in the
amount of $10k.
Vera Savcic
COO & CFO
Seed
Tel +1
EFTA00949286
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation@gmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
Adam Bly
Founder & CEO
Seed
T +1 646 502-7041 I F +1 646 502-7040
I @Seed
@adambly
NOTICE: If received in error, please destroy and notify sender, and make no further use, disclosure, or
distribution. This email and any attachments may contain information subject to confidentiality
obligations, and sender does not waive confidentiality or privilege.
EFTA00949287